Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs Vincerx Pharma, Inc. (VINC)

Lunai Bioworks Inc. and Vincerx Pharma, Inc. are both Biotechnology companies. Lunai Bioworks Inc. is the larger, with a market value of $830.0K against $250.0K — 3.3× the size. Vincerx Pharma, Inc. has the higher net margin (0.00% vs −3,761.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Vincerx Pharma, Inc. leads on 6 and Lunai Bioworks Inc. on 5.

Valuation

Metric LNAI VINC Biotechnology median
P/E n/m n/m 10.60
P/S 5.68 n/m 9.40
P/B n/m 0.03 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.17 0.66
EV/Sales 0.25 n/m 9.02
Earnings yield (640.81%) (46,330.00%) (32.88%)
Free cash flow yield (988.00%) (32,262.57%) (23.13%)

Profitability

Metric LNAI VINC Biotechnology median
Gross margin (3.48%) 0.00% 68.51%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% (3,136.43%) (51.96%)
Return on assets (39.21%) (287.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LNAI VINC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 98.77% 58.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI VINC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.11 1.79 4.97
Net debt to EBITDA 0.20 0.17 1.01

Dividend

Metric LNAI VINC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LNAI VINC Biotechnology median
Market cap 830.00k 250.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack